The use of different methods for rapid determination of the ESR induces DAS28 misclassification in clinical practice

Clinical and Experimental Rheumatology

Volumn 28, Issue 4, 2010, Pages 477-482

  van der Maas, Aatke ^a   van den Ende, Cornelia H M ^a   van Eerd, Juliëtte ^a   Fransen, Jaap ^b   den Broeder, Alfons A ^a  

^a Sint Maartenskliniek ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

DAS28; Disease activity; ESR; Monitoring; RA

Indexed keywords

BIOLOGICAL MARKER;

AGED; ARTICLE; BLOOD; BLOOD EXAMINATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; PSORIATIC ARTHRITIS; REPRODUCIBILITY; RHEUMATIC FEVER; SPONDYLOARTHROPATHY;

AGED; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; CROSS-SECTIONAL STUDIES; FEMALE; HEMATOLOGIC TESTS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RHEUMATIC FEVER; SEVERITY OF ILLNESS INDEX; SPONDYLARTHROPATHIES;

EID: 79952059095     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. GRIGOR C, CAPELL H, STIRLING A et al. Effect of a treatment strategy for tight control of rheumatoid arthritis (the TICORA study): a single blind randomised controlled trial. Lancet 2004; 364: 263-9.
2. FRANSEN J, MOENS HB, SPEYER I, VAN RIEL PLCM Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005; 64: 1294-8.
3. GOEKOOP-RUITERMAN YP, DE VRIES-BOUWSTRA JK, ALLAART CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005; 52: 3381-90.
4. GOEKOOP-RUITERMAN YP, DE VRIES-BOUWSTRA JK, KERSTENS PJ et al. DAS-driven therapy versus routine care in patients with recent-onset active Rheumatoid Arthritis. Ann Rheum Dis 2010; 69: 65-9.
5. PREVOO ML, VAN 'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LBA, VAN RIEL PLCM: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
6. PREVOO ML, VAN RIEL PLCM, VAN 'T HOF MA et al. Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol 1993; 32: 589-94.
7. VAN GESTEL AM, PREVOO ML, VAN 'T HOF MA, VAN RIJSWIJK MH, VAN DE PUTTE LBA, VAN RIEL PLCM: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996 Jan; 39: 34-40.
8. FRANSEN J, CREEMERS MC, VAN RIEL PLCM Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004; 43: 1252-5.
9. WESTERGREN A: Studies of the suspension stability of the blood pulmonary tuberculosis. Acta Med Scand 1921; 54: 247-82.
10. CASTREJÓN I, ORTIZ AM, GARCÍA-VICUÑA R et al. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 2008; 26: 769-75.
11. SALAFFI F, CIMMINO MA, LEARDINI G et al. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol 2009; 24: 552-9.
12. MICHAUD K, MIKULS TR, CALL SE et al. Poor to modest agreement between rheumatoid arthritis response measures in clinical practice. Clin Exp Rheumatol 2009; 27: 633-40.
13. PLEBANI M, DE TONI S, SANZARI MC, BERNARDI D, STOCKREITER E The TEST 1 automated system: a new method for measuring the erythrocyte sedimentation rate. Am J Clin Pathol 1998; 110: 334-40.
14. GIAVARINA D, CAPUZZO S, CAUDURO F, CARTA M, SOFFIATI G Internal quality control for erythrocyte sedimentation rate measured by TEST-1 Analyzer. Clin Lab 2002; 48: 459-62.
15. DE JONG N, SEWKARANSING I, SLINGER J, RIJSDIJK JJM: Erythrocyte sedimentation rate by the Test-1 analyzer. Clin Chem 2000; 46: 881-2.
16. BLAND JM, ALTMAN DG Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-60.
17. LEVITUS M, PELLICIA A, VAN DE STADT RJ, VOSKUYL AE, BOUMAN AA: Is the Alifax Test-1TH useful to determine the Disease Activity Score (DAS28) in rheumatoid arthritis patients? Clin Rheumatol 2009; 28: 469-74
18. COMBE B, LANDEWE R, LUKAS C et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 34-45.
19. KENNEDY T, MCCABE C, STRUTHERS G et al. BSR guidelines on standards of care for persons with rheumatoid arthritis. Rheumatology 2005; 44: 553-6.
20. VAN RIEL PLCM, BARENDSEN BC, CROONENBORG JJ, FOLMER H, FORMSMA SA, HAZES JMW Richtlijn Diagnostiek en behandeling van reumatoide artritis. 2009 Nederlandse vereniging Reumatologie. Van Zuiden communications. ISBN 978-90-8523-178-3.